Glory Health Industry (SEHK:2329) - Prezzo delle azioni, notizie e analisi

2329 Panoramica delle azioni

Glory Health Industry Limited, una holding di investimento, sviluppa e gestisce proprietà immobiliari nella Repubblica Popolare Cinese. Maggiori dettagli

2329 analisi fondamentale
Punteggio fiocco di neve
Valutazione	2/6
Crescita futura	0/6
Prestazioni passate	0/6
Salute finanziaria	2/6
Dividendi	0/6

Analisi del rischio

Il debito non è ben coperto dal flusso di cassa operativo

Gli utili sono diminuiti del 65.2% all'anno negli ultimi 5 anni

Prezzo delle azioni volatile negli ultimi 3 mesi

Non ha una capitalizzazione di mercato significativa ( HK$609M )

Glory Health Industry Limited Concorrenti

Chuang's Consortium International

SEHK:367

HK$593.8m

Japan Kyosei Group

SEHK:627

HK$738.8m

Peking University Resources (Holdings)

SEHK:618

HK$347.7m

Cosmopolitan International Holdings

SEHK:120

HK$320.1m

Storia dei prezzi e prestazioni

Riepilogo dei massimi storici, delle variazioni e dei cali di prezzo di tutti i tempi per Glory Health Industry
Prezzi storici delle azioni
Prezzo attuale dell'azione	HK$0.13
Massimo di 52 settimane	HK$0.25
Minimo di 52 settimane	HK$0.021
Beta	-0.011
1Variazione di 1 mese	4.03%
Variazione a 3 mesi	7.50%
Variazione di 1 anno	248.65%
3Variazione a 3 anni	-65.14%
Variazione a 5 anni	-91.68%
Variazione dall'IPO	-94.84%

Notizie e aggiornamenti recenti

We Discuss Why Glory Health Industry Limited's (HKG:2329) CEO Compensation May Be Closely Reviewed

Jun 21

Recent updates

We Discuss Why Glory Health Industry Limited's (HKG:2329) CEO Compensation May Be Closely Reviewed

Jun 21

We Think Shareholders May Want To Consider A Review Of Guorui Properties Limited's (HKG:2329) CEO Compensation Package

Jun 23

Guorui Properties (HKG:2329) Has A Somewhat Strained Balance Sheet

May 13

Guorui Properties'(HKG:2329) Share Price Is Down 73% Over The Past Five Years.

Jan 31

Should You Use Guorui Properties's (HKG:2329) Statutory Earnings To Analyse It?

Jan 10

What Kind Of Shareholders Hold The Majority In Guorui Properties Limited's (HKG:2329) Shares?

Dec 20

Guorui Properties (HKG:2329) Has A Somewhat Strained Balance Sheet

Dec 03

Rendimenti per gli azionisti

	2329	HK Real Estate	HK Mercato
7D	0%	-3.9%	-2.8%
1Y	248.6%	-12.8%	10.0%

Ritorno vs Industria: 2329 ha superato il Hong Kong Real Estate che ha restituito -12.8 % nell'ultimo anno.

Rendimento vs Mercato: 2329 ha superato il mercato Hong Kong che ha restituito 10 % nell'ultimo anno.

Volatilità dei prezzi

Is 2329's price volatile compared to industry and market?
2329 volatility
2329 Average Weekly Movement	13.6%
Real Estate Industry Average Movement	10.1%
Market Average Movement	8.9%
10% most volatile stocks in HK Market	19.0%
10% least volatile stocks in HK Market	4.2%

Prezzo delle azioni stabile: Il prezzo delle azioni di 2329 è stato volatile negli ultimi 3 mesi.

Volatilità nel tempo: La volatilità settimanale di 2329 è diminuita da 27% a 14% nell'ultimo anno, ma è comunque superiore al 75% delle azioni Hong Kong.

Informazioni sull'azienda

Fondato	I dipendenti	AMMINISTRATORE DELEGATO	Sito web
1994	552	Zhangsun Zhang	www.glorypty.com

Glory Health Industry Limited, una holding di investimento, sviluppa e gestisce proprietà immobiliari nella Repubblica Popolare Cinese. La società opera attraverso quattro segmenti: Sviluppo immobiliare, Costruzione di terreni primari e servizi di sviluppo, Investimento immobiliare e Gestione immobiliare e servizi correlati. Il segmento Sviluppo immobiliare sviluppa e vende proprietà commerciali e residenziali.

Glory Health Industry Limited Riepilogo dei fondamenti

Come si confrontano gli utili e i ricavi di Glory Health Industry con la sua capitalizzazione di mercato?
2329 statistiche fondamentali
Capitalizzazione di mercato	HK$608.89m
Guadagni(TTM)	-HK$381.47m
Ricavi(TTM)	HK$2.18b

0.3x

Rapporto P/S

-1.5x

Rapporto P/E

2329 è sopravvalutato?

Vedi Fair Value e analisi di valutazione

Guadagni e ricavi

Statistiche chiave sulla redditività dall'ultima relazione sugli utili (TTM)
2329 Conto economico (TTM)
Ricavi	CN¥2.04b
Costo del fatturato	CN¥1.84b
Profitto lordo	CN¥201.85m
Altre spese	CN¥557.60m
Guadagni	-CN¥355.76m

Ultimi guadagni dichiarati

Jun 30, 2024

Prossima data di guadagno

n/a

Utile per azione (EPS)	-0.08
Margine lordo	9.91%
Margine di profitto netto	-17.47%
Rapporto debito/patrimonio netto	161.3%

Come si è comportato 2329 nel lungo periodo?

Vedi performance storica e confronto

2329 Panoramica delle azioni

Analisi del rischio

Glory Health Industry Limited Concorrenti

SEHK:367

HK$593.8m

SEHK:627

HK$738.8m

SEHK:618

HK$347.7m

SEHK:120

HK$320.1m

Storia dei prezzi e prestazioni

Notizie e aggiornamenti recenti

First half 2024 earnings released: CN¥0.013 loss per share (vs CN¥0.06 loss in 1H 2023)

Glory Health Industry Limited to Report First Half, 2024 Results on Aug 30, 2024

We Discuss Why Glory Health Industry Limited's (HKG:2329) CEO Compensation May Be Closely Reviewed

Glory Health Industry Limited, Annual General Meeting, Jun 28, 2024

Full year 2023 earnings released: CN¥0.13 loss per share (vs CN¥0.20 loss in FY 2022)

Glory Health Industry Limited to Report Fiscal Year 2023 Results on Mar 28, 2024

Recent updates

First half 2024 earnings released: CN¥0.013 loss per share (vs CN¥0.06 loss in 1H 2023)

Glory Health Industry Limited to Report First Half, 2024 Results on Aug 30, 2024

We Discuss Why Glory Health Industry Limited's (HKG:2329) CEO Compensation May Be Closely Reviewed

Glory Health Industry Limited, Annual General Meeting, Jun 28, 2024

Full year 2023 earnings released: CN¥0.13 loss per share (vs CN¥0.20 loss in FY 2022)

Glory Health Industry Limited to Report Fiscal Year 2023 Results on Mar 28, 2024

Glory Health Industry Limited Appoints Lam Yuen Ling Eva as Company Secretary

Glory Health Industry Limited Announces the Resignation of Liu Chengjiang as Independent Non-Executive Director, Chairman of the Internal Control Committee and Member of the Audit Committee

Glory Health Industry (HKG:2329) Has Debt But No Earnings; Should You Worry?

First half 2023 earnings released: CN¥0.06 loss per share (vs CN¥0.15 loss in 1H 2022)

Glory Health Industry Limited Announces Resignation of Lai Siming as an Independent Non-Executive Director

Glory Health Industry Limited to Report First Half, 2023 Results on Aug 31, 2023

Now 32% undervalued after recent price drop

Glory Health Industry Limited Announces Resignation of Kwong Yin Ping Yvonne as Joint Company Secretary and Authorised Representative, Effective July 1, 2023

Glory Health Industry Limited Announces Retirement of Luo Zhenbang as Independent Non-Executive Director

Glory Health Industry Limited Announces Resignation of Zheng Jin as Joint Company Secretary and an Authorised Representative

Health Check: How Prudently Does Glory Health Industry (HKG:2329) Use Debt?

Glory Health Industry Limited, Annual General Meeting, Jun 30, 2023

Now 21% undervalued after recent price drop

Glory Health Industry Limited Appoints Liu Chengjiang as Independent Non-Executive Director, Chairman of Internal Control Committee and Member of Audit Committee

Now 21% undervalued after recent price drop

A Look At The Fair Value Of Glory Health Industry Limited (HKG:2329)

Full year 2022 earnings released: CN¥0.20 loss per share (vs CN¥0.051 profit in FY 2021)

Glory Health Industry Limited Announces Resignation of Ms. Chen Jingru as Independent Non-Executive Director, Chairman of the Internal Control Committee of the Company and Member of the Audit Committee

Less than half of directors are independent

Glory Health Industry (HKG:2329) Has Debt But No Earnings; Should You Worry?

First half 2022 earnings released: CN¥0.15 loss per share (vs CN¥0.06 profit in 1H 2021)

Glory Health Industry Limited Provides Earnings Guidance for Six Months Ended June 30, 2022

Glory Health Industry Limited to Report First Half, 2022 Results on Aug 31, 2022

Less than half of directors are independent

We Think Guorui Properties (HKG:2329) Is Taking Some Risk With Its Debt

Full year 2021 earnings released: EPS: CN¥0.051 (vs CN¥0.022 in FY 2020)

Guorui Properties Limited to Report Fiscal Year 2021 Results on Mar 31, 2022

Less than half of directors are independent

First half 2021 earnings released: EPS CN¥0.06 (vs CN¥0.016 in 1H 2020)

Here's Why Guorui Properties (HKG:2329) Is Weighed Down By Its Debt Load

We Think Shareholders May Want To Consider A Review Of Guorui Properties Limited's (HKG:2329) CEO Compensation Package

Guorui Properties (HKG:2329) Has A Somewhat Strained Balance Sheet

Full year 2020 earnings released: EPS CN¥0.022 (vs CN¥0.19 in FY 2019)

Chairman & President recently bought HK$1.6m worth of stock

Full year 2020 earnings released: EPS CN¥0.022 (vs CN¥0.19 in FY 2019)

Guorui Properties Limited to Report Fiscal Year 2020 Results on Mar 31, 2021

New 90-day low: HK$0.73

Guorui Properties'(HKG:2329) Share Price Is Down 73% Over The Past Five Years.

Should You Use Guorui Properties's (HKG:2329) Statutory Earnings To Analyse It?

New 90-day low: HK$0.74

What Kind Of Shareholders Hold The Majority In Guorui Properties Limited's (HKG:2329) Shares?

New 90-day low: HK$0.83

Guorui Properties (HKG:2329) Has A Somewhat Strained Balance Sheet

New 90-day low: HK$0.84

New 90-day low: HK$0.94

First half earnings released

New 90-day low - HK$1.10

First half earnings released

Guorui Properties Limited to Report First Half, 2020 Results on Aug 31, 2020

Rendimenti per gli azionisti

Volatilità dei prezzi

Informazioni sull'azienda

Glory Health Industry Limited Riepilogo dei fondamenti

0.3x